Larkspur Health Acquisition registered with the SEC to offer 7.5 million units to raise up to $75 million. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant; whole warrants exercisable at $11.50.
A.G.P./Alliance Global Partners is the sole book-running manager. The underwiters have a 45-day option to buy 1.125 million shares and 562,500 redeemable warrantsto cover any over-allotments.
The new SPAC plans to target companies within the biotechnology sector in the United States.
Larkspur ios led by Chairman and CEO Daniel O’Connor, who is CEO , president and director of OncoSec Medical Incorporated, a NJ based biotech company.
The SPAC said it has applied for a Nasdaq listing under the LSPRU. Read more.
